Sitemap
November 07, 2022 Articles
Filter by Available Specialty
- ‘Clear’ reduction in CV, renal outcomes with SGLT2 inhibitors across all high-risk groups
- ‘Quad therapy’ strategy may improve BP control vs. angiotensin receptor blocker monotherapy
- ‘Stand up, speak up’ to increase female representation in trial leadership
- A ‘Meta’-morphosis of meetings? Maybe
- ACR: Any consistent exercise ‘advised over no exercise’ for rheumatoid arthritis
- Air pollution raises mortality risk, worsens lung function in fibrotic ILD
- American Joint Replacement Registry releases 2022 annual report on THA, TKA procedures
- Artificial intelligence, machine learning may identify TJA implants prior to revisions
- Beckley acquires Eleusis, strengthening pipeline of psychedelic-based therapeutics
- Belantamab mafodotin-blmf fails to extend PFS in advanced multiple myeloma
- Chinese herbal medicine may improve outcomes after STEMI
- CMS releases final rule on payments for dialysis care
- Combined VIR-2218, VIR-3434 therapy reduces HBV surface antigen
- Cushing’s syndrome treatment maintains reductions in urinary free cortisol for 12 months
- Early diagnosis of CKD can slow eGFR decline
- ECP data show long-term IOP control with low-risk profile
- Familial link to diabetes affects risk for diabetic retinopathy, DME differently
- From one eye whisperer to another: A decade in review
- From skeptic to advocate: Metaverse in medicine
- Girl presents with unilateral visually significant cataract
- High MELD score not linked to worse survival for living donor liver transplant recipients
- Higher patient global assessment threshold improves RA remission criteria agreement
- How 'whole-person' integrative care can best address chronic pain
- Initial cryoballoon ablation strategy bests drug therapy for long-term AF progression
- Intensive treatment strategy after discharge for HF reduces death, readmission at 180 days
- Invasive, conservative strategies confer similar long-term mortality in stable ischemia
- Low-income, underrepresented populations at greater risk for chemical exposures
- Nicholas J. Vogelzang, MD, posthumously receives humanitarian award named in his honor
- No ‘singular definitive etiology’ found for acute hepatitis outbreak in children
- Olpasiran cut Lp(a) levels by more than 95% in patients with atherosclerotic CVD
- Ophthalmologists debate Oxervate vs. neurotization for neurotrophic keratopathy
- Ophthalmologists should improve their knowledge of the metaverse
- Ophthalmology takes the plunge into the metaverse
- Osteopathic manipulation medicine may reduce burnout in health care workers
- Pandemic contributes to disparities for Black women seeking fertility treatment
- Patients with disseminated gonococcal infection lack usual symptoms
- Physical fitness associated with reduced risk for allergic conjunctivitis in children
- Prediction tools can be developed for those with first-episode psychosis
- Race, not neighborhood deprivation, predicts IVF success
- Researchers characterize patients who might benefit from early COPD intervention
- Revaccination guidance after cell therapy established for some, ‘evolving’ for others
- Ruxolitinib cream 1.5% produces ‘meaningful’ outcomes in vitiligo
- Sidney Kimmel Cancer Center names program co-leader
- Spectral domain OCT can be utilized for pupillometry
- Study validates single-item screen for cannabis use disorder in primary care
- Surgery tops endovascular procedures in CLI, but only if saphenous vein conduit adequate
- Tactics in inflationary times to keep staffing costs in line
- Third COVID-19 vaccine dose reduces infection, critical disease risk in cirrhosis by 80%
- Top in cardiology: Lower GI bleeding risk with apixaban; menstrual cycles and CVD risk
- Trials for advanced renal cell carcinoma often use restrictive eligibility criteria
- Upadacitinib has ‘favorable’ benefit-risk profile for atopic dermatitis
- Viatris to acquire Oyster Point, Famy Life Sciences
- Video review of surgical cases vital to continuing education
- VIDEO: Antibodies can provide useful insights into neuropathy
- VIDEO: Bylvay improves pruritus, reduces serum bile acids in Alagille syndrome
- VIDEO: Cabozantinib regimen 'reasonably well tolerated,' not effective over monotherapy
- VIDEO: Individualized thyroid cancer therapy helps move away from 'cookie-cutter approach'
- VIDEO: Takeaways from AHA 2022 with B. Hadley Wilson, MD, FACC
- Virtual visits confer similar weight loss to in-person visits for adults with obesity